ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 248 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2022. The put-call ratio across all filers is 52.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,397 | +13.3% | 6,499 | +8.7% | 0.00% | 0.0% |
Q2 2023 | $75,361 | -3.4% | 5,981 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $78,052 | -35.8% | 5,981 | -13.2% | 0.00% | -20.0% |
Q4 2022 | $121,504 | +15.8% | 6,888 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $104,904 | +2.7% | 6,888 | 0.0% | 0.01% | +25.0% |
Q2 2022 | $102,149 | -42.6% | 6,888 | -12.9% | 0.00% | -33.3% |
Q1 2022 | $177,998 | -70.5% | 7,904 | -75.8% | 0.01% | -25.0% |
Q4 2021 | $603,278 | +33.0% | 32,698 | -3.6% | 0.01% | +14.3% |
Q3 2021 | $453,564 | -36.7% | 33,924 | -12.3% | 0.01% | -30.0% |
Q2 2021 | $716,226 | +2.7% | 38,694 | -16.7% | 0.01% | 0.0% |
Q1 2021 | $697,522 | +1.2% | 46,455 | -2.7% | 0.01% | 0.0% |
Q4 2020 | $689,524 | +77.4% | 47,751 | 0.0% | 0.01% | +42.9% |
Q3 2020 | $388,693 | +6.0% | 47,751 | -11.8% | 0.01% | 0.0% |
Q2 2020 | $366,535 | -39.8% | 54,141 | -37.4% | 0.01% | -46.2% |
Q1 2020 | $609,150 | -33.9% | 86,527 | -7.9% | 0.01% | -13.3% |
Q4 2019 | $921,962 | -14.3% | 93,934 | -4.1% | 0.02% | -16.7% |
Q3 2019 | $1,075,304 | -6.6% | 97,933 | -1.1% | 0.02% | -5.3% |
Q2 2019 | $1,151,463 | +20.4% | 99,008 | -1.3% | 0.02% | +11.8% |
Q1 2019 | $956,643 | -1.9% | 100,277 | -0.9% | 0.02% | -15.0% |
Q4 2018 | $975,337 | -32.3% | 101,176 | +0.1% | 0.02% | -23.1% |
Q3 2018 | $1,439,621 | -99.9% | 101,026 | -5.0% | 0.03% | +23.8% |
Q2 2018 | $1,275,972,000 | -3.2% | 106,331 | -0.4% | 0.02% | +10.5% |
Q1 2018 | $1,318,424,000 | +86524.4% | 106,755 | +2.1% | 0.02% | -5.0% |
Q4 2017 | $1,522,000 | -62.9% | 104,573 | -63.7% | 0.02% | -23.1% |
Q3 2017 | $4,101,000 | +11.0% | 288,223 | -0.5% | 0.03% | 0.0% |
Q2 2017 | $3,695,000 | +73.1% | 289,572 | +71.9% | 0.03% | +73.3% |
Q1 2017 | $2,135,000 | +20.9% | 168,405 | -2.6% | 0.02% | +15.4% |
Q4 2016 | $1,766,000 | -23.4% | 172,984 | -1.1% | 0.01% | -23.5% |
Q3 2016 | $2,305,000 | +3.3% | 174,983 | -0.4% | 0.02% | 0.0% |
Q2 2016 | $2,232,000 | -2.9% | 175,710 | +1.0% | 0.02% | -5.6% |
Q1 2016 | $2,298,000 | -11.5% | 173,932 | +3.0% | 0.02% | -10.0% |
Q4 2015 | $2,596,000 | +24.7% | 168,798 | +0.5% | 0.02% | +33.3% |
Q3 2015 | $2,082,000 | -0.7% | 167,919 | +9.6% | 0.02% | 0.0% |
Q2 2015 | $2,096,000 | +14.8% | 153,205 | +0.4% | 0.02% | +15.4% |
Q1 2015 | $1,825,000 | -2.9% | 152,586 | +3.7% | 0.01% | 0.0% |
Q4 2014 | $1,880,000 | -3.8% | 147,203 | +1.0% | 0.01% | -7.1% |
Q3 2014 | $1,955,000 | -11.1% | 145,750 | +6.4% | 0.01% | -6.7% |
Q2 2014 | $2,198,000 | -8.8% | 136,976 | +2.5% | 0.02% | -11.8% |
Q1 2014 | $2,409,000 | +19.3% | 133,609 | +2.3% | 0.02% | +21.4% |
Q4 2013 | $2,020,000 | +4.6% | 130,663 | +0.6% | 0.01% | -6.7% |
Q3 2013 | $1,931,000 | +4.6% | 129,859 | -9.0% | 0.02% | 0.0% |
Q2 2013 | $1,846,000 | – | 142,688 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 10,507,149 | $138,799,000 | 8.42% |
Tamarack Advisers, LP | 1,650,000 | $21,797,000 | 7.63% |
Blue Harbour Group | 10,759,695 | $142,136,000 | 4.78% |
BROADVIEW ADVISORS LLC | 1,095,800 | $14,476,000 | 2.08% |
Rovida Advisors Inc. | 752,400 | $9,939,000 | 2.04% |
Adirondack Research & Management Inc. | 361,259 | $4,772,000 | 1.73% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,104,400 | $14,589,000 | 1.70% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 14,401,161 | $190,239,000 | 1.62% |
FULLER & THALER ASSET MANAGEMENT, INC. | 5,077,304 | $67,071,000 | 1.30% |
Iguana Healthcare Management, LLC | 250,000 | $3,303,000 | 1.21% |